Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

IMPORTANCE: A decision to initiate aspirin therapy for primary prevention of cardiovascular disease (CVD) requires consideration of both treatment benefits and harms. The most significant harm associated with aspirin is major bleeding, yet there is a paucity of data on bleeding risk in suitable comm...

詳細記述

保存先:
書誌詳細
出版年:JAMA
主要な著者: Selak, Vanessa, Kerr, Andrew, Poppe, Katrina, Wu, Billy, Harwood, Matire, Grey, Corina, Jackson, Rod, Wells, Sue
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2018
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583689/
https://ncbi.nlm.nih.gov/pubmed/29946729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.8194
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料